ONE YEAR STUDY OF BOVINE TYPE I COLLAGEN VS PLACEBO IN SSC

SSC 中牛 I 型胶原蛋白与安慰剂的一年研究

• 批准号: 7375427
• 负责人: ARNOLD E POSTLETHWAITE
• 金额: $ 0.23万
• 依托单位: UNIVERSITY OF TENNESSEE HEALTH SCI CTR
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7375427
• 关键词: YEAR; STUDY; BOVINE; TYPE; COLLAGEN

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This research project will test the hypothesis that orally administered soluble bovine CI will decrease laboratory parameters characteristic of active SSc in patients whose PBMC show in vitro reactivity to bovine CI.

这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金，因此可能会出现在其他CRISE条目中。列出的机构是针对中心的，而不一定是针对调查员的机构。本研究项目将验证一种假设，即口服可溶性牛CI会降低PBMC对牛CI具有体外反应性的患者活跃的SSC的实验室参数。